Electronic Pharmacotherapy Risk Management

NCT00828490 | Completed

• 2 other identifiers: 249877570516-1
• Study Type: observational
• Target: 174,000
• Locations: 1 country
• Sites: 1

Brief Summary

The purpose of the Utah ePRM (electronic Pharmacotherapy Risk Management) project is to improve quality and safety of medication use while simultaneously controlling costs and detecting fraud and abuse.

Conditions

Asthma; Mental Health; Pain

Keywords

Fraud and Abuse; opioids

Study Arms (6)

Pediatric Asthmatics

Medicaid beneficiaries ≤21 years of age who meet the HEDIS criteria for persistent asthma

Behavioral: provider feedback; Behavioral: patient intervention; Behavioral: Process-level

Antipsychotic Therapy

Medicaid beneficiaries ≥18 years of age and enrolled ≥6 months of the past 12 months with enrollment in at least one of the past 3 months and ≥3 antipsychotic Rx within past 12 months

Behavioral: provider feedback; Behavioral: patient intervention; Behavioral: Process-level

Bipolar Therapy

Medicaid beneficiaries ≥18 years of age and enrolled ≥6 months of the past 12 months with enrollment in at least one of the past 3 months and a diagnosis of Bipolar in past 3 years, and ≥ 1 antidepressant Rx in past 6 months, and no mood stabilizer in past 6 months.

Behavioral: provider feedback; Behavioral: patient intervention; Behavioral: Process-level

Opioid Therapy

Medicaid beneficiaries ≥18 years and enrolled ≥6 of prior 12 months with enrollment in ≥1 of prior 3 months and ≥1 opioid fill in prior 3 months and none of the following in prior 12 months: Hospice CPT code or Primary diagnosis of cancer or Oncology CPT code

Behavioral: Process-level

Fraud and Abuse

Medicaid beneficiaries who filled at least 3 opioid Rx in the last 12 months

Pediatric Antipsychtotic Therapy

Medicaid beneficiaries \<18 years of age with at least 3 antipsychotic Rx's in the past year.

Interventions

provider feedback BEHAVIORAL

The provider-level intervention includes a targeted review of trigger-flagged beneficiaries' drug utilization history and an information packet sent to providers which includes patient-specific pharmacy and medical claims history, patient specific recommendations, and provider comparative profiling.

Antipsychotic Therapy; Bipolar Therapy; Pediatric Asthmatics

patient intervention BEHAVIORAL

The patient intervention arm includes the provider-level intervention mentioned above in addition to Medication Therapy Management Services (MTMS), a program that provides patients one-on-one therapy counseling administered by community pharmacists who have completed an MTMS certificate program.

Antipsychotic Therapy; Bipolar Therapy; Pediatric Asthmatics

Process-level BEHAVIORAL

The process-level intervention includes the provider-level intervention plus in-clinic evidence-based quality improvement workshops with opportunity for CME credit

Antipsychotic Therapy; Bipolar Therapy; Opioid Therapy; Pediatric Asthmatics

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

all medicaid recipients in the salt lake area

You may qualify if:

• All medicaid recipients and providers with in the salt lake area

You may not qualify if:

• each participant much be a Medicaid recipient

Sponsors & Collaborators

• University of Utah: lead
• Utah Department of Health: collaborator

Study Sites (1)

Multi-clinic site

Salt Lake City, Utah, United States

Location

MeSH Terms

Conditions

Asthma; Psychological Well-Being; Pain

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases; Lung Diseases, Obstructive; Lung Diseases; Respiratory Hypersensitivity; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases; Personal Satisfaction; Behavior; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Officials

• Jonathan R Nebeker, M.D., M.S.

  VASLCHCS

  PRINCIPAL INVESTIGATOR

• Gary Oderda, PharmD, M.P.H.

  University of Utah

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER

Study Record Dates

• First Submitted: January 23, 2009
• First Posted: January 26, 2009
• Study Start: July 1, 2007
• Primary Completion: March 1, 2010
• Study Completion: March 1, 2010
• Last Updated: March 23, 2010

Record last verified: 2010-03

Locations

US (1)